UB Paderborn / Katalog / Suche / in CDI

Prenylcysteine oxidase 1, A novel player in atherosclerosis

ATHEROSCLEROSIS, 2021-08, Vol.331, p.e18-e18

2021

Volltextzugriff (PDF)

Prenylcysteine oxidase 1, an emerging player in atherosclerosis

Communications biology, 2021-09, Vol.4 (1), p.1109-1109, Article 1109

2021

Volltextzugriff (PDF)

The absence of PCSK9 determines a lower neointimal formation in response to perivascular carotid collar placement

Atherosclerosis, 2016-09, Vol.252, p.e233-e234

2016

Volltextzugriff (PDF)

Proprotein convertase subtilisin/kexin type 9 deficient mice are protected from neointima formation in carotid artery injury model

Atherosclerosis, 2015-07, Vol.241 (1), p.e60-e60

2015

Volltextzugriff (PDF)

Proprotein convertase subtilisin/kexin type 9 deficient mice are protected from neointima formation in carotid artery injury model

Atherosclerosis, 2014-08, Vol.235 (2), p.e21-e22

2014

Volltextzugriff (PDF)

The absence of the EDA alternative spliced isoform of fibronectin promotes smooth muscle cells migration and results in neo-intimal hyperplasia

Atherosclerosis, 2015-07, Vol.241 (1), p.e45-e45

2015

Volltextzugriff (PDF)

New insights into the pharmacodynamic and pharmacokinetic properties of statins

Pharmacology & therapeutics (Oxford), 1999-12, Vol.84 (3), p.413-428

1999

Volltextzugriff (PDF)

Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?

Nutrition, metabolism, and cardiovascular diseases, 2001-10, Vol.11 (5), p.328-343

2001

Volltextzugriff (PDF)

Safety considerations for statins

Current opinion in lipidology, 2002-12, Vol.13 (6), p.637-644

2002

Volltextzugriff (PDF)

Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering

Arteriosclerosis, thrombosis, and vascular biology, 2002-04, Vol.22 (4), p.692

2002

Volltextzugriff (PDF)

Rupture of the atherosclerotic plaque: does a good animal model exist?

Arteriosclerosis, thrombosis, and vascular biology, 2003-04, Vol.23 (4), p.535

2003

Volltextzugriff (PDF)

Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content

Biochemical journal, 1997-03, Vol.322 ( Pt 3) (3), p.893-896

1997

Volltextzugriff (PDF)

PKC activity in rat C6 glioma cells : changes associated with cell cycle and simvastatin treatment

Biochemical and biophysical research communications, 1994-04, Vol.200 (2), p.1143-1149

1994

Volltextzugriff (PDF)

PKC Activity in Rat C 6 Glioma Cells: Changes Associated with Cell Cycle and Simvastatin Treatment

Biochemical and biophysical research communications, 1994-04, Vol.200 (2), p.1143-1149

1994

Volltextzugriff (PDF)

Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin

Thrombosis and haemostasis, 2002-04, Vol.87 (4), p.748

2002

Volltextzugriff (PDF)

Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells

Pharmacological research, 2007-08, Vol.56 (2), p.160-167

2007

Volltextzugriff (PDF)

Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses

Human gene therapy, 1997-09, Vol.8 (14), p.1645-1650

1997

Volltextzugriff (PDF)

PROAPOPTOTIC EFFECT OF ATORVASTATIN ON STIMULATED RABBIT SMOOTH MUSCLE CELLS

Pharmacological research, 1997-08, Vol.36 (2), p.115-121

1997

Volltextzugriff (PDF)

In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin

Cancer research (Chicago, Ill.), 1995-02, Vol.55 (3), p.597-602

1995

Volltextzugriff (PDF)

Effect of lercanidipine and its (R)‐enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits

British journal of pharmacology, 1998-12, Vol.125 (7), p.1471-1476

1998

Volltextzugriff (PDF)

Upregulation and activation of Stat6 precede vascular smooth muscle cell proliferation in carotid artery injury model

Arteriosclerosis, thrombosis, and vascular biology, 2000-04, Vol.20 (4), p.931

2000

Volltextzugriff (PDF)

Marked neointimal lipoprotein lipase increase in distinct models of proclivity to atherosclerosis: a feature independent of endothelial layer integrity

Atherosclerosis, 2001-05, Vol.156 (1), p.91-101

2001

Volltextzugriff (PDF)

The menopause and lipid metabolism: strategies for cardiovascular disease prevention

Current opinion in lipidology, 1997-08, Vol.8 (4), p.229-235

1997

Volltextzugriff (PDF)

3.P.209 Dual effect of HMG-CoA reductase inhibitors on vascular reactivity in normo- and hyper-cholesterolemic rabbit aortas

Atherosclerosis, 1997-10, Vol.134 (1-2), p.242-242

1997

Volltextzugriff (PDF)

765 NITRIC OXIDE-DONATING STATINS EXERT BENEFICIAL EFFECTS ON ACUTE VASCULAR INFLAMMATION IN NORMOCHOLESTEROLEMIC RABBITS

Atherosclerosis. Supplements, 2011-06, Vol.12 (1), p.160-160

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Prenylcysteine oxidase 1, A novel player in atherosclerosis

Prenylcysteine oxidase 1, an emerging player in atherosclerosis

The absence of PCSK9 determines a lower neointimal formation in response to perivascular carotid collar placement

Proprotein convertase subtilisin/kexin type 9 deficient mice are protected from neointima formation in carotid artery injury model

Proprotein convertase subtilisin/kexin type 9 deficient mice are protected from neointima formation in carotid artery injury model

The absence of the EDA alternative spliced isoform of fibronectin promotes smooth muscle cells migration and results in neo-intimal hyperplasia

New insights into the pharmacodynamic and pharmacokinetic properties of statins

Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?

Safety considerations for statins

Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering

Rupture of the atherosclerotic plaque: does a good animal model exist?

Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content

PKC activity in rat C6 glioma cells : changes associated with cell cycle and simvastatin treatment

PKC Activity in Rat C 6 Glioma Cells: Changes Associated with Cell Cycle and Simvastatin Treatment

Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin

Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells

Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses

PROAPOPTOTIC EFFECT OF ATORVASTATIN ON STIMULATED RABBIT SMOOTH MUSCLE CELLS

In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin

Effect of lercanidipine and its (R)‐enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits

Upregulation and activation of Stat6 precede vascular smooth muscle cell proliferation in carotid artery injury model

Marked neointimal lipoprotein lipase increase in distinct models of proclivity to atherosclerosis: a feature independent of endothelial layer integrity

The menopause and lipid metabolism: strategies for cardiovascular disease prevention

3.P.209 Dual effect of HMG-CoA reductase inhibitors on vascular reactivity in normo- and hyper-cholesterolemic rabbit aortas

765 NITRIC OXIDE-DONATING STATINS EXERT BENEFICIAL EFFECTS ON ACUTE VASCULAR INFLAMMATION IN NORMOCHOLESTEROLEMIC RABBITS

Suchergebnisse filtern